Literature DB >> 2805618

Tolerability and efficacy of oral chrysotherapy in patients with Sjögren's syndrome secondary to rheumatoid arthritis (SS-RA).

A Mathieu1, R Pala, P Nurchis, L Contu.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2805618     DOI： 10.1007/bf02030358

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN： 0770-3198            Impact factor:   2.980


× No keyword cloud information.
  13 in total

Review 1.  SJOEGREN'S SYNDROME. A CLINICAL, PATHOLOGICAL, AND SEROLOGICAL STUDY OF SIXTY-TWO CASES.

Authors:  K J BLOCH; W W BUCHANAN; M J WOHL; J J BUNIM
Journal:  Medicine (Baltimore)       Date:  1965-05       Impact factor: 1.889

2.  Genetic differences between primary and secondary sicca syndrome.

Authors:  H M Moutsopoulos; D L Mann; A H Johnson; T M Chused
Journal:  N Engl J Med       Date:  1979-10-04       Impact factor: 91.245

3.  Sjögren's syndrome. Proposed criteria for classification.

Authors:  R I Fox; C A Robinson; J G Curd; F Kozin; F V Howell
Journal:  Arthritis Rheum       Date:  1986-05

Review 4.  Sjogren's syndrome. 2. Clinical associations and immunological phenomena.

Authors:  K Whaley; J Webb; B A McAvoy; G R Hughes; P Lee; R N MacSween; W W Buchanan
Journal:  Q J Med       Date:  1973-07

5.  Chrysotherapy. A prospective study.

Authors:  N O Rothermich; V K Philips; W Bergen; M H Thomas
Journal:  Arthritis Rheum       Date:  1976 Nov-Dec

6.  An attempt to predict the response to gold therapy in rheumatoid arthritis.

Authors:  J D O'Duffy; W M O'Fallon; G G Hunder; F C McDuffie; S B Moore
Journal:  Arthritis Rheum       Date:  1984-11

7.  HLA system and side effects of gold salts and D-penicillamine treatment of rheumatoid arthritis.

Authors:  T Bardin; A Dryll; N Debeyre; A Ryckewaert; L Legrand; A Marcelli; J Dausset
Journal:  Ann Rheum Dis       Date:  1982-12       Impact factor: 19.103

8.  Comparison of auranofin, gold sodium thiomalate, and placebo in the treatment of rheumatoid arthritis. A controlled clinical trial.

Authors:  J R Ward; H J Williams; M J Egger; J C Reading; E Boyce; M Altz-Smith; C O Samuelson; R F Willkens; M A Solsky; S P Hayes
Journal:  Arthritis Rheum       Date:  1983-11

9.  An analysis of worldwide safety experience with auranofin.

Authors:  M A Heuer; R G Pietrusko; R W Morris; B J Scheffler
Journal:  J Rheumatol       Date:  1985-08       Impact factor: 4.666

10.  HLA-DR antigens and toxic reaction to sodium aurothiomalate and D-penicillamine in patients with rheumatoid arthritis.

Authors:  P H Wooley; J Griffin; G S Panayi; J R Batchelor; K I Welsh; T J Gibson
Journal:  N Engl J Med       Date:  1980-08-07       Impact factor: 91.245
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.